Home > Sustainable & Smart Technologies > Nanoparticle Analysis Market
Nanoparticle Analysis Market size exceeded USD 2.5 billion in 2021 and is estimated to grow at over 6% CAGR from 2022 to 2028.
The industry is gaining traction due to increasing funding activities in pharmaceutical research in developing nations. Growing research & development activities in the nanoparticle analysis field, financial backing from public-private partnerships, and rise in R&D outsourcing to China by global pharmaceutical & biopharmaceutical businesses is further enhancing the market demand. The surge on annual spending of the biopharmaceutical sector around the globe will drive the adoption of nanoparticle analysis systems.
To get more details on this report: Request Free Sample PDF
The COVID-19 pandemic moderately impacted the global nanoparticle analysis market. The industrial sector was significantly hit during the first wave, resulting in decreased instrument production and limitations on raw material & particle transportation, among other issues. In the second half of FY2021, the pandemic facilitated the development of novel technologies for medical research facilities and medical device manufacturers. The increasing efforts of biopharma & biotech companies globally to create COVID-19 vaccines are fueling the market growth.
|Market Size in 2021:||2.5 billion (USD)|
|Forecast Period:||2022 to 2028|
|Forecast Period 2022 to 2028 CAGR:||6%|
|2028 Value Projection:||4 billion (USD)|
|Historical Data for:||2017 to 2021|
|No. of Pages:||239|
|Tables, Charts & Figures:||203|
|Segments covered:||Technology, Analysis Type, Application|
|Pitfalls & Challenges:|
To get details on how to order this report click here
The nanoparticle tracking analysis segment is slated to witness around 8% gains from 2022 to 2028. The growth can be credited to the growing acceptance of nanoparticle tracking analysis in healthcare applications such as exosomes, macrovesicles, extracellular vesicles characterization, and viral vaccine research & development. This nanoparticle analysis technology helps companies in drug developments and manufacturing workflows through raw material selection processes and quality control. Several market participants are focusing on expanding their distribution channels to scale up their presence.
The particle size analysis segment held more than 30% of the nanoparticle analysis market share in 2021 owing rising adoption in pharmaceutical and biopharmaceutical sectors. It helps companies in drug development and manufacturing workflow through raw material selection processes and quality control. Nanoparticle shape & size might also influence multiple essential production factors such as the bioavailability & durability of Active Pharmaceutical Ingredients (APIs), dosage uniformity, and other quality aspects.
To tailor this report to your specific requirements: Customize this Report
Medical device companies are expected to register growth rate of above 7% through 2028 owing to the integration of nano-ink & nano-coating technology for manufacturing medical electronic devices. Several medical devices including vitro diagnostic devices, heart valves, dental implants, bone void fillers, catheters, stents, orthopedic implants, and cancer therapeutics are manufactured using nanoparticle analysis techniques.
Several OEMs are focusing on collaborative approaches to develop new medical electronic devices by integrating nanotechnology with the help of nanoparticle analysis systems. For instance, in January 2022, XTPL, a nano-printing solution provider in Europe, announced its collaboration with Nano Dimension Ltd. to co-develop metallic nanoparticle-based conductive inks. These inks are designed to allow end users to manufacture Additively Manufactured Electronics (AME) for medical, healthcare, commercial and other industrial applications.
To check discounted pricing for this report: Request Discount
The Asia Pacific nanoparticle analysis market size valued at nearly USD 900 million in 2021. Regional governments’ focus on investment to support nanotechnology research activities will spur the industry statistics. For instance, according to the Indian Ministry of Electronics & Information Technology article updated in April 2020, MeitY announced a set of fundamental initiatives to promote nanotechnology research and innovation in the country.
The Ministry initiated the Indian Nanoelectronics Users Programme, which is being incorporated at the Centre of Excellence in Nanoelectronics (CEN). This has enabled the R&D community in the country to access government nanofabrication facilities for conducting research & development programs in nanoelectronics.
The key players operating in the nanoparticle analysis market include Horiba Ltd., Shimadzu Corporation, Agilent Technologies, Inc., Bruker Corporation, Hitachi, Ltd., and Thermo Fisher Scientific.
The industry participants are proactively focusing on new product developments & launches to gain a competitive advantage in the market. For instance, in June 2021, Horiba signed a collaboration led by the Cell and Gene Therapy (CGT) Catapult to accelerate the production of Process Analytical Technologies (PAT) for cell & gene therapy. It is a type of nanoparticle analysis instrument that offers a combination of experience & competence in technology, pharmaceutics, therapy, and patient demand.
Click here to buy sections of this report
Market, By Technology
Market, By Analysis Type
Market, By Application
The above information has been provided for the following regions and countries: